ChiCTR2400083172 版本V1.0 版本创建时间2024/04/17 14:36:37 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400083172 

最近更新日期:

Date of Last Refreshed on:

2024-04-17 14:36:32 

注册时间:

Date of Registration:

2024-04-17 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

出院后家庭氧疗对支气管肺发育不良早产儿临床结局的影响

Public title:

Effect of home oxygen therapy on clinical outcomes of premature infants with bronchopulmonary dysplasia after discharge

注册题目简写:

English Acronym:

研究课题的正式科学名称:

出院后家庭氧疗对支气管肺发育不良早产儿临床结局的影响

Scientific title:

Effect of home oxygen therapy on clinical outcomes of premature infants with bronchopulmonary dysplasia after discharge

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

周涛 

研究负责人:

王建辉 

Applicant:

Zhou Tao 

Study leader:

Wang Jianhui 

申请注册联系人电话:

Applicant telephone:

+86 180 8016 7420

研究负责人电话:

Study leader's telephone:

+86 136 7842 8167

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

2022120598@stu.cqmu.edu.cn

研究负责人电子邮件:

Study leader's E-mail:

wangjh805@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

重庆市渝中区中山二路136号

研究负责人通讯地址:

重庆市渝中区中山二路136号

Applicant address:

136 Second Zhongshan Road, Yuzhong District,Chongqing, China

Study leader's address:

136 Second Zhongshan Road, Yuzhong District,Chongqing, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

重庆医科大学附属儿童医院

Applicant's institution:

Children's Hospital of Chongqing Medical University

研究负责人所在单位:

重庆医科大学附属儿童医院

Affiliation of the Leader:

Children's Hospital of Chongqing Medical University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

(2023)年伦审(研)第(253)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

重庆医科大学附属儿童医院医学研究伦理委员会

Name of the ethic committee:

Institutional Review Board of Children's Hospital of Chongqing Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2023-07-20 00:00:00

伦理委员会联系人:

蔡诗蓉

Contact Name of the ethic committee:

Cai Shirong

伦理委员会联系地址:

重庆市两江新区金渝大道20号

Contact Address of the ethic committee:

No.20 Jinyu Avenue Liangjiang New Area, Chongqing, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 23 6837 0035

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

重庆医科大学附属儿童医院

Primary sponsor:

Children's Hospital of Chongqing Medical University

研究实施负责(组长)单位地址:

重庆市渝中区中山二路136号

Primary sponsor's address:

136 Second Zhongshan Road, Yuzhong District,Chongqing, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆市

市(区县):

Country:

China

Province:

Chongqing

City:

单位(医院):

重庆医科大学附属儿童医院

具体地址:

重庆市渝中区中山二路136号

Institution
hospital:

Children's Hospital of Chongqing Medical University

Address:

136 Second Zhongshan Road, Yuzhong District,Chongqing, China

经费或物资来源:

Source(s) of funding:

None

Target disease:

Bronchopulmonary dysplasia

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

1 分析BPD患儿中出院后需行HOT治疗的高危因素 2 了解出院后行HOT治疗的一般情况,包括氧气支持程度、停氧纠正胎龄、用氧时间等 3 比较出院后行HOT治疗的BPD患儿与未行HOT治疗的BPD患儿的临床结局差别,包括呼吸不良结局、体格及神经发育评估。  

Objectives of Study:

1. To analyze the risk factors of HOT treatment after discharge in children with BPD 2 Understand the general situation of HOT treatment after discharge, including the degree of oxygen support, the gestational age of oxygen withdrawal correction, and the duration of oxygen use 3 To compare the clinical outcomes, including adverse respiratory outcomes, physical and neurodevelopmental assessments, between discharged BPD children treated with HOT and those not treated with HOT.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

满足以下所有条件:(1)孕周≤32周;(2)根据2018年NICHD标准,诊断为BPD的患儿;(3)所有检查和程序均经重庆医科大学附属儿童医院批准并在入组前获得患者父母的书面知情同意书。

Inclusion criteria

All of the following conditions are met:(1) Gestational age ≤32 weeks; (2) Children diagnosed with BPD according to the 2018 NICHD criteria; (3) All examinations and procedures were approved by Children's Hospital Affiliated to Chongqing Medical University and written informed consent of patients' parents was obtained before enrollment.

排除标准:

有下列任一情况:(1)存在明显先天畸形;(2)患儿严重气道软化,需额外呼吸支持;(3)家属签字提前出院的早产儿;(4)早产儿在住院期间死亡;(5)早产儿在纠正胎龄36周前出院。

Exclusion criteria:

Any of the following: (1) There is an obvious congenital malformation; (2) Children with severe airway softening need additional respiratory support; (3) Premature infants who are discharged from hospital early signed by their family members; (4) Premature infants die while in hospital; (5) Preterm infants are discharged 36 weeks before their gestational age is corrected.

研究实施时间:

Study execute time:

From 2024-04-22 00:00:00 To 2024-06-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-04-22 00:00:00 To 2024-06-30 00:00:00  

干预措施:

Interventions:

组别:

进行家庭氧疗的支气管肺发育不良的早产儿

样本量:

39

Group:

Preterm infants with bronchopulmonary dysplasia undergoing home oxygen therapy

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

未进行家庭氧疗的支气管肺发育不良的早产儿

样本量:

39

Group:

Preterm infants with bronchopulmonary dysplasia without home oxygen therapy

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

重庆市 

市(区县):

 

Country:

China 

Province:

Chongqing 

City:

 

单位(医院):

重庆医科大学附属儿童医院 

单位级别:

三级甲等 

Institution
hospital:

Children's Hospital of Chongqing Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

门急诊就诊次数

指标类型:

主要指标

Outcome:

Number of outpatient and emergency visits

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

再入院次数

指标类型:

主要指标

Outcome:

Number of readmissions

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

神经发育

指标类型:

次要指标

Outcome:

Neurodevelopment

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

体格发育

指标类型:

次要指标

Outcome:

Physical development

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

父母压力评分

指标类型:

次要指标

Outcome:

Parental stress score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

呼吸结局

指标类型:

主要指标

Outcome:

Respiratory outcome

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

N/A

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

编制病历记录表,并采用Epidata软件编制电子病历收集表,进行资料收集和数据管理。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The CRF will be built based on the study design. To use Epidata to collect and manage data.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2024-04-17 14:36:32